3.06.25: OGEN: Advances ONP-002 Clinical Development with Investigator’s Brochure Submission for Phase II mTBI Trial
2.24.25: OGEN: Breaking Barriers in Concussion Care with ONP-002 and Nasal Delivery Innovation OUTPERFORM Rating
